Pulse Biosciences Inc PLSE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
-
Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
-
ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million
-
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
-
Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results
-
Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026
-
Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
Trading Information
- Previous Close Price
- $26.32
- Day Range
- $25.36–27.43
- 52-Week Range
- $12.56–31.00
- Bid/Ask
- $24.00 / $27.94
- Shares Outstanding
- 69.21M
- Market Cap
- $1.89B
- Volume/Avg
- 465 / 336,741
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2,467.81
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 116
- Website
- https://www.pulsebiosciences.com
Valuation
|
Metric
|
PLSE
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 28.21 |
Price/Sales | 2,467.81 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PLSE
|
|---|---|
Quick Ratio | 6.99 |
Current Ratio | 7.26 |
Interest Coverage | — |
Quick Ratio
PLSE
Profitability
|
Metric
|
PLSE
|
|---|---|
Return on Assets (Normalized) | −51.84% |
Return on Equity (Normalized) | −60.35% |
Return on Invested Capital (Normalized) | −59.13% |
Return on Assets
PLSE
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|XCx<N!c> | LOCK|D&g | $138B | |||
| Becton Dickinson & Co
BDX
| LOCK|@<P | LOCK|q$!J | $43B | |||
| Alcon Inc
ALC
| LOCK|>^w%ZD | LOCK|yg!D^ | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|q^BCB!K | LOCK|BgR& | $33B | |||
| ResMed Inc
RMD
| LOCK|pr<^%>? | LOCK|>$P#$ | $29B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|$?&^@GKb | LOCK|V<j | $25B | |||
| The Cooper Companies Inc
COO
| LOCK|N!>c#$ | LOCK|y&wB | $14B | |||
| Solventum Corp
SOLV
| LOCK|%#%$<J | LOCK|#b | $14B | |||
| Align Technology Inc
ALGN
| LOCK|GY#rgF@ | LOCK|<HW$ | $13B | |||
| Baxter International Inc
BAX
| LOCK|?^ | LOCK|%Jb?$ | $11B |
United States